KRAS and lung carcinoma: The above results showed that the high expression of LAD1 predicted poor outcomes in LUAD and affected K-Ras and EGF signaling, suggesting that the high expression of LAD1 may affect the chemotherapeutic drug sensitivity of lung cancer cells.